RESOLVE: Resolving the Burden of Low Back Pain in Military Service Members and Veterans: A Pragmatic Clinical Trial

Sponsor
United States Naval Medical Center, San Diego (U.S. Fed)
Overall Status
Not yet recruiting
CT.gov ID
NCT04494490
Collaborator
Walter Reed National Military Medical Center (U.S. Fed), University of Pittsburgh (Other), Naval Health Research Center (U.S. Fed), James A. Haley Veterans Administration Hospital (U.S. Fed), VA New York Harbor Healthcare System (U.S. Fed)
7,260
2
22

Study Details

Study Description

Brief Summary

The RESOLVE trial will provide a pragmatic approach to evaluate whether Physical Therapy Clinical Practice Guideline adherence can reduce pain, disability and downstream healthcare utilization for low back pain within the Departments of Defense and Veterans Affairs healthcare systems.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Clinical Practice Guidelines and Psychologically Informed Physical Therapy training/audit/feedback
N/A

Detailed Description

Physical therapy (PT) is frequently used for the management of low back pain (LBP) within the U.S. Departments of Defense (DoD) and Veterans Affairs (VA). However, variations in PT practice patterns and utilization of ineffective interventions lower the quality and increase the cost of care. Although, adherence to the clinical practice guidelines (CPGs) can improve outcomes and cost effectiveness of LBP care, PT CPG adherence rates remain below 50%. The RESOLVE trial will evaluate the effectiveness of an active PT CPG implementation strategy using an education/audit/feedback model for reducing pain, disability, medication use and cost of LBP care within the DoD and VA healthcare systems. The RESOLVE trial will include 3300 to 7260 patients with LBP from five DoD and VA medical facilities, using a stepped-wedge study design. An education/audit/feedback model will be used to encourage the physical therapists to better adhere to the PT CPG recommendations. The primary outcomes of disability and pain intensity will be measured with the Oswestry Disability Index and the Defense and Veterans Pain Rating Scale. Secondary outcomes will include the LBP-related medical resource utilization and biopsychosocial predictors of PT outcomes. Statistical analyses will be based on intention to treat principles and will use linear mixed models to compare treatment conditions, and examine the interactions between treatment and sub-grouping status. The RESOLVE trial will provide a pragmatic approach to evaluate whether PT CPG adherence can reduce pain, disability and downstream healthcare utilization for LBP within the DoD and VA healthcare systems.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
7260 participants
Allocation:
Randomized
Intervention Model:
Sequential Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Resolving the Burden of Low Back Pain in Military Service Members and Veterans: A Pragmatic Clinical Trial
Anticipated Study Start Date :
Jan 1, 2021
Anticipated Primary Completion Date :
Nov 1, 2022
Anticipated Study Completion Date :
Nov 1, 2022

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Usual Care Condition

During the usual care condition the therapists will be instructed "to act as usual," that is, to read the guidelines on low back pain if they have read previous published guidelines and not read these guidelines if they have not read any other guidelines.

Active Comparator: CPG+PIPT Condition

An active Clinical Practice Guidelines (CPG) implementation strategy will be utilized with an education component in Psychologically Informed Physical Therapy (PIPT) with peer opinion leaders and a monthly audit/feedback on CPG adherence rates and patient outcomes

Behavioral: Clinical Practice Guidelines and Psychologically Informed Physical Therapy training/audit/feedback
The aim of the active training strategy is to improve the knowledge and skills of physical therapists with regard to evidence-based physical therapy with an emphasis on active treatments and PIPT for the treatment of patients with low back pain and to encourage increased adherence with CPGs. This Continuing Education (CE) training session will be offered to all therapists regardless of study participation. During the CE training session, focus will be placed on interventions that have been shown to be effective, such as interactive education and discussion, feedback, and reminders.

Outcome Measures

Primary Outcome Measures

  1. Pain [Every two weeks over course of PT treatment, up to 12 weeks]

    Change in Defense and Veterans Pain Rating Scale (DVPRS) score

  2. Disability [Every two weeks over course of PT treatment, up to 12 weeks]

    Change in Oswestry Disability Index (ODI)

Secondary Outcome Measures

  1. Healthcare Utilization [One year]

    Change in frequency of healthcare utilization:The medical resources of interest for this trial will include: 1) referrals to specialists (e.g., orthopedists, spine surgeons, physiatrists) and other health care providers, and 2) tests (e.g., x-rays, MRIs), surgical procedures (e.g., epidural steroid injections, laminectomy).

  2. Healthcare Utilization [One year]

    Change in extent of healthcare utilization:The medical resources of interest for this trial will include: 1) referrals to specialists (e.g., orthopedists, spine surgeons, physiatrists) and other health care providers, and 2) tests (e.g., x-rays, MRIs), surgical procedures (e.g., epidural steroid injections, laminectomy).

  3. Analgesic Medication Use [One year]

    Change in frequency of analgesic medication use: prescribing patterns for key drug classes commonly used for low back pain management such as non-steroidal anti-inflammatory drugs (NSAIDs), acetaminophen (Tylenol), opioid analgesics, skeletal muscle relaxants, antidepressants (e.g., tricyclic antidepressants and duloxetine), and drugs for neuropathic pain (e.g., gabapentin).

  4. Analgesic Medication Use [One year]

    Change in extent of analgesic medication use: prescribing patterns for key drug classes commonly used for low back pain management such as non-steroidal anti-inflammatory drugs (NSAIDs), acetaminophen (Tylenol), opioid analgesics, skeletal muscle relaxants, antidepressants (e.g., tricyclic antidepressants and duloxetine), and drugs for neuropathic pain (e.g., gabapentin).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 64 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Receiving physical therapy care for low back pain in an outpatient physical therapy setting
Exclusion Criteria:
  • Over 64 years of age

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • United States Naval Medical Center, San Diego
  • Walter Reed National Military Medical Center
  • University of Pittsburgh
  • Naval Health Research Center
  • James A. Haley Veterans Administration Hospital
  • VA New York Harbor Healthcare System

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Shawn Farrokhi, PT, PhD, Facility Research Director, DoD-VA Extremity Trauma and Amputation Center of Excellence (EACE), United States Naval Medical Center, San Diego
ClinicalTrials.gov Identifier:
NCT04494490
Other Study ID Numbers:
  • NMCSD.2018.0034
First Posted:
Jul 31, 2020
Last Update Posted:
Jul 31, 2020
Last Verified:
Jul 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 31, 2020